A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care.
Juvenile idiopathic arthritis
Quality improvement
Quality indicators
Quality of care
Journal
Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438
Informations de publication
Date de publication:
19 03 2020
19 03 2020
Historique:
received:
21
12
2019
accepted:
09
03
2020
entrez:
21
3
2020
pubmed:
21
3
2020
medline:
12
1
2021
Statut:
epublish
Résumé
The evaluation of quality of care in juvenile idiopathic arthritis (JIA) is critical for advancing patient outcomes but is not currently part of routine care across all centers in Canada. The study objective is to review the current landscape of JIA quality measures and use expert panel consensus to define key performance indicators (KPIs) that are important and feasible to collect for routine monitoring in JIA care in Canada. Thirty-seven candidate KPIs identified from a systematic review were reviewed for inclusion by a working group including 3 pediatric rheumatologists. A shortlist of 14 KPIs was then assessed using a 3-round modified Delphi panel based on the RAND/UCLA Appropriateness Method. Ten panelists across Canada participated based on their expertise in JIA, quality measurement, or lived experience as a parent of a child with JIA. During rounds 1 and 3, panelists rated each KPI on a 1-9 Likert scale on themes of importance, feasibility, and priority. In round 2, panelists participated in a moderated in-person discussion that resulted in minor modifications to some KPIs. KPIs with median scores of ≥ 7 on all 3 questions without disagreement were included in the framework. Ten KPIs met the criteria for inclusion after round 3. Five KPIs addressed patient assessments: pain, joint count, functional status, global assessment of disease activity, and the clinical Juvenile Arthritis Disease Activity Score (cJADAS). Three KPIs examined access to care: wait times for consultation, access to pediatric rheumatologists within 1 year of diagnosis, and frequency of clinical follow-up. Safety was addressed through KPIs on tuberculous screening and laboratory monitoring. KPIs examining functional status using the Childhood Health Assessment Questionnaire (CHAQ), quality of life, uveitis, and patient satisfaction were excluded due to concerns about feasibility of measurement. The proposed KPIs build upon existing KPIs and address important processes of care that should be measured to improve the quality of JIA care. The feasibility of capturing these measures will be tested in various data sources including the Understanding Childhood Arthritis Network (UCAN) studies. Subsequent work should focus on development of meaningful outcome KPIs to drive JIA quality improvement in Canada and beyond.
Sections du résumé
BACKGROUND
The evaluation of quality of care in juvenile idiopathic arthritis (JIA) is critical for advancing patient outcomes but is not currently part of routine care across all centers in Canada. The study objective is to review the current landscape of JIA quality measures and use expert panel consensus to define key performance indicators (KPIs) that are important and feasible to collect for routine monitoring in JIA care in Canada.
METHODS
Thirty-seven candidate KPIs identified from a systematic review were reviewed for inclusion by a working group including 3 pediatric rheumatologists. A shortlist of 14 KPIs was then assessed using a 3-round modified Delphi panel based on the RAND/UCLA Appropriateness Method. Ten panelists across Canada participated based on their expertise in JIA, quality measurement, or lived experience as a parent of a child with JIA. During rounds 1 and 3, panelists rated each KPI on a 1-9 Likert scale on themes of importance, feasibility, and priority. In round 2, panelists participated in a moderated in-person discussion that resulted in minor modifications to some KPIs. KPIs with median scores of ≥ 7 on all 3 questions without disagreement were included in the framework.
RESULTS
Ten KPIs met the criteria for inclusion after round 3. Five KPIs addressed patient assessments: pain, joint count, functional status, global assessment of disease activity, and the clinical Juvenile Arthritis Disease Activity Score (cJADAS). Three KPIs examined access to care: wait times for consultation, access to pediatric rheumatologists within 1 year of diagnosis, and frequency of clinical follow-up. Safety was addressed through KPIs on tuberculous screening and laboratory monitoring. KPIs examining functional status using the Childhood Health Assessment Questionnaire (CHAQ), quality of life, uveitis, and patient satisfaction were excluded due to concerns about feasibility of measurement.
CONCLUSIONS
The proposed KPIs build upon existing KPIs and address important processes of care that should be measured to improve the quality of JIA care. The feasibility of capturing these measures will be tested in various data sources including the Understanding Childhood Arthritis Network (UCAN) studies. Subsequent work should focus on development of meaningful outcome KPIs to drive JIA quality improvement in Canada and beyond.
Identifiants
pubmed: 32192528
doi: 10.1186/s13075-020-02151-w
pii: 10.1186/s13075-020-02151-w
pmc: PMC7083048
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
53Subventions
Organisme : Genome Canada, Ontario Genomics, Genome Alberta, the Ontario Ministry of Economic Development, Job Creation and Trade; The Arthritis Society, Alberta Children's Hospital Research Institute, University of Calgary, UCAN Utrecht, and the Hospital for Sick Chi
ID : None
Pays : International
Organisme : Canada Research Chair (Health Systems and Services Research, 2008-2018) and the Arthur J.E. Child Chair in Rheumatology Research.
ID : None
Pays : International
Références
Rheumatology (Oxford). 2010 Jul;49(7):1406-8
pubmed: 20173199
Arthritis Care Res (Hoboken). 2019 Feb 14;:
pubmed: 30762291
Arthritis Care Res (Hoboken). 2019 Jun;71(6):717-734
pubmed: 31021516
J Rheumatol. 2016 Mar;43(3):530-40
pubmed: 26773106
Arthritis Care Res (Hoboken). 2011 Jan;63(1):10-6
pubmed: 20842714
Ann Rheum Dis. 2016 Jan;75(1):190-5
pubmed: 25362042
Rheumatology (Oxford). 2018 Jan 1;57(1):140-151
pubmed: 29069424
Arthritis Care Res (Hoboken). 2016 Oct;68(10):1390-401
pubmed: 27159835
Arthritis Care Res (Hoboken). 2011 Jan;63(1):2-9
pubmed: 20945349
Ann Rheum Dis. 2018 Jun;77(6):819-828
pubmed: 29643108
BMC Health Serv Res. 2019 Aug 14;19(1):572
pubmed: 31412858
Curr Opin Rheumatol. 2016 Mar;28(2):110-6
pubmed: 26780426
J Rheumatol. 2018 Nov;45(11):1501-1508
pubmed: 29907674
Arthritis Res Ther. 2019 Dec 5;21(1):270
pubmed: 31806043
Arthritis Care Res (Hoboken). 2018 May;70(5):741-749
pubmed: 28732134
J Rheumatol. 2018 Feb;45(2):274-283
pubmed: 29142026
Arthritis Care Res (Hoboken). 2018 Jun;70(6):842-850
pubmed: 29450976
Rheumatology (Oxford). 2013 Dec;52(12):2203-7
pubmed: 24014649
J Rheumatol. 2013 May;40(5):715-24
pubmed: 23418376
JAMA. 1988 Sep 23-30;260(12):1743-8
pubmed: 3045356
Ann Rheum Dis. 2015 Oct;74(10):1854-60
pubmed: 24842571